Neurology News

In patients with primary progressive MS who experience persistent inflammatory activity, disease-modifying therapies were linked to a reduced risk for becoming wheelchair dependent, according to a study in JAMA Neurology.

We are on the cusp of taking some of the largest steps in recent history to make medicines more affordable for our patients, and it is critical that we successfully pass the legislation needed to achieve this as an issue of health equity.

In this week’s edition, a Labcorp blood test identifies signs of neurodegenerative disease; the FDA approves an oral treatment for partial seizures in teens; ketamine shows efficacy in epilepsy; and more.

Cognivue, a neuroscience company, announced it will launch a national study to differentiate the effectiveness of its cognitive assessment systems.

CHARLOTTE, N.C. – Research shows that switching to daylight savings time not only causes short-term daytime sleepiness in adolescents, it may be linked to chronic mental health issues, Christina F. Chick, PhD, said at the SLEEP meeting.

Biogen Inc. announced that the FDA has accepted a new drug application for tofersen, an investigational drug to treat superoxide dismutase 1 ALS.

NYU Langone Health has been named the top hospital in the United States for neurology and neurosurgery, according to the latest survey from U.S. News & World Report.

RapidAI has announced FDA clearance for Rapid Hyperdensity, a diagnostic tool that enables physicians to quickly assess the severity of injury in patients with acute conditions, such as traumatic brain injury and brain hemorrhages.

CHARLOTTE, N.C. — Deviation from typical sleep pattern was found to affect daily metacognition in college students, according to a poster presented at the SLEEP meeting.

A majority of stroke survivors received no treatment for depression, with sociodemographic differences driving the persistent treatment gap, according to a study published in Neurology.